Table 3. Short tandem repeat typing results for 30 iterative samples from 15 patients (two per patient).
No. of patients | Background of the patient | No. of Induced samples | Type of sample | Interval between first and second sample (days) | Cq | Induced sTRPj amplicon size (bp) | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
#022 | #108 | #138 | #189 | #278 | #279 | ||||||
07 | Hematology | 109*** | Induced sputum | 20.7 | 141/144 | 138 | 169/175 | 195/219 | 189 | 181/190 | |
110*** | Induced sputum | +1 | 21.6 | 141/144 | 138 | 175/169 | 195/219 | 189 | 181/190 | ||
10 | Others | 240 | Induced sputum | 27.2 | 144 | 138 | 169 | 219/207* | 189 | 190/175*/178* | |
243 | Induced sputum | +7 | 26.8 | 144 | 138 | 169/175* | 219 | 189 | 190 | ||
12 | Hematology | 197 | Induced sputum | 28.2 | 138 | 138 | 172 | 195 | 189 | 181 | |
199 | BAL | +1 | 22.6 | 138 | 138 | 172 | 195 | 189 | 181 | ||
13 | Others | 079 | BAL | 31.3 | 138/141* | 138 | 169 | 221/195 | 189 | 181/187 | |
080 | Induced sputum | 0 | 30.0 | 138 | 138 | 169 | 221/195 | 189 | 181/187 | ||
14 | HIV-positive | 319 | Induced sputum | 20.6 | 141/138 | 138 | 172 | 219 | 189/191 | 181/190 | |
320 | Induced sputum | 0 | 23.0 | 141/138 | 138 | 172 | 219 | 189/191 | 181/190 | ||
15 | Others | 045*** | BAL | 20.4 | 138 | 138*/144 | 169/163** | 193/207** | 189 | 175 | |
053*** | BAL | +14 | 28.6 | 138 | 144 | 169/151** | 193/195** | 189 | 175 | ||
16 | HIV-positive | 311 | Induced sputum | 23.2 | 138 | 138 | 163/169 | 205/193 | 189 | 175/178 | |
316 | BAL | +14 | 22.0 | 138 | 138 | 163/169 | 205/193 | 189 | 175/178 | ||
17 | Renal transplant | 165 | Induced sputum | 23.5 | 144 | 138 | 169 | 219 | 189 | 190 | |
168 | BAL | +1 | 28.9 | 144 | 138 | 169/166* | 219 | 189 | 190 | ||
18 | HIV-positive | 272 | Induced sputum | 16.8 | 138/141* | 138 | 169/166* | 219/205/193 | 191 | 181 | |
282 | BAL | +18 | 26.7 | 138 | 138 | 169 | 219/205/193 | 191 | 181 | ||
19 | HIV-positive | 249 | Induced sputum | 26.0 | 138 | 138 | 172 | 195 | 189 | 181 | |
252 | BAL | +1 | 17.8 | 138 | 138 | 172 | 195 | 189 | 181 | ||
20 | HIV-positive | 030 | Induced sputum | 23.1 | 138 | 138 | 169 | 205/195 | 189 | 181 | |
032 | BAL | +2 | 19.2 | 138 | 138 | 169 | 205/195 | 189 | 181 | ||
21 | HIV-positive | 132*** | Induced sputum | 28.2 | 138/141* | 138 | 169/163 | 207** | 189/191 | 178/181*/184 | |
134*** | Induced sputum | +1 | 26.4 | 138 | 138 | 169/163 | 205** | 191/189 | 184/178 | ||
22 | HIV-positive | 309*** | Induced sputum | 20.1 | 141 | 138 | 169/175 | 183**/207 | 189 | 178 | |
321*** | BAL | +37 | 28.1 | 141 | 138 | 169/175 | 207/205** | 189 | 178 | ||
23 | HIV-positive | 212*** | Induced sputum | 28.9 | 138/144* | 138 | 157*/169 | 205 | 189** | 181 | |
215*** | BAL | +3 | 29.1 | 138 | 138 | 169 | 205 | 191** | 181 | ||
25 | HIV-positive | 158 | Induced sputum | 21.2 | 138 | 138 | 169/163* | 205 | 189 | 178/181/184 | |
160 | Induced sputum | +1 | 27.4 | 138 | 138 | 169 | 205 | 189 | 178/181/184 |
When multiple alleles were detected, the major allele is written first.
* gain or loss of allele between the two samples.
** allele replacement between the two samples.
*** samples in which the ratio of a given marker differed between the first and second sample.